Intermittent androgen suppression in the management of prostate cancer: A phase II comparative study

被引：0
|
作者：
Irani J. [1 ]
机构：
[1] Centre Hospitalier Universitaire, Poitiers
来源：
Prostate Cancer and Prostatic Diseases | 2000年 / 3卷 / Suppl 1期
关键词：
D O I：
10.1038/sj.pcan.4500444
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：S20 / S20
相关论文
共 50 条
  • [1] Phase II study of intermittent androgen suppression (IAS) in prostate cancer patients.
    Bracarda, S
    Rosi, P
    De Angelis, V
    Mearini, E
    Porena, M
    Tonato, M
    ANNALS OF ONCOLOGY, 2000, 11 : 31 - 31
  • [2] Intermittent androgen suppression in the management of prostate cancer
    Crook, JM
    Szumacher, E
    Malone, S
    Huan, S
    Segal, R
    UROLOGY, 1999, 53 (03) : 530 - 534
  • [3] Intermittent androgen suppression for prostate cancer
    Buchan, Nicholas C.
    Goldenberg, S. Larry
    NATURE REVIEWS UROLOGY, 2010, 7 (10) : 552 - 560
  • [4] Intermittent androgen suppression for prostate cancer
    Nicholas C. Buchan
    S. Larry Goldenberg
    Nature Reviews Urology, 2010, 7 : 552 - 560
  • [5] Intermittent androgen suppression (IAS) in prostate cancer
    Farrugia, D
    Ansell, W
    Williams, G
    Oliver, RTD
    ANNALS OF ONCOLOGY, 1998, 9 : 60 - 60
  • [6] Intermittent androgen suppression in the treatment of prostate cancer
    Kadiev, R. M.
    Tolchanov, S. A.
    INTERNATIONAL JOURNAL OF ANDROLOGY, 2005, 28 : 119 - 119
  • [7] Intermittent androgen suppression in patients with prostate cancer
    de la Taille, A
    Zerbib, M
    Conquy, S
    Amsellem-Ouazana, D
    Thiounn, N
    Flam, TA
    Debré, B
    BJU INTERNATIONAL, 2003, 91 (01) : 18 - 22
  • [8] Intermittent androgen suppression with leuprolide and flutamide for prostate cancer: A pilot study
    Higano, CS
    Ellis, W
    Russell, K
    Lange, PH
    UROLOGY, 1996, 48 (05) : 800 - 804
  • [9] Long-term side-effects of intermittent androgen suppression therapy in prostate cancer: results of a phase II study
    Malone, S
    Perry, G
    Segal, R
    Dahrouge, S
    Crook, J
    BJU INTERNATIONAL, 2005, 96 (04) : 514 - 520
  • [10] Mature results of the Ottawa phase II study of intermittent androgen-suppression therapy in prostate cancer: Clinical predictors of outcome
    Malone, Shawn
    Perry, Gad
    Eapen, Libni
    Segal, Roanne
    Gallant, Victor
    Dahrouge, Simone
    Crook, Juanita
    Spaans, Johanna N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 68 (03): : 699 - 706
12345